Related Experiment Video
Updated: Jul 13, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
Characterizing the Crosstalk Between Programmed Cell Death Pathways in Cytokine Storm With an Agent-Based Model
Solomon Feuerwerker1, R Chase Cockrell2, Gary An1
1Department of Surgery, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.
Programmed cell death pathways (PCDPs) show complex crosstalk, aiding pathogen defense but complicating cytokine storm (CS) treatment. Computational modeling reveals redundancies challenge immunomodulation therapies for CS.
Area of Science:
- Immunology
- Computational Biology
- Pathogen Response
Background:
- Programmed cell death pathways (PCDPs), including apoptosis, pyroptosis, and necroptosis, exhibit extensive crosstalk, creating a redundant host defense system.
- While beneficial against diverse pathogens, the inflammatory nature of pyroptosis and necroptosis complicates therapeutic control of cytokine storm (CS)-induced organ dysfunction.
Purpose of the Study:
- To develop a computational model simulating the crosstalk between PCDPs.
- To enhance understanding of PCDP interactions during microbial infections and evaluate potential therapeutic interventions for CS.
Main Methods:
- A literature review of apoptosis, pyroptosis, and necroptosis was conducted.
- An agent-based model, the programmed cell death agent-based model (PCDABM), was developed using NetLogo.
- Simulations involved microbial infections (IAV, EPEC, SE), silencing of PCDPs, and blockade of TNF and IL-1.
Main Results:
- The PCDABM successfully simulated cross-activation of PCDPs and microbial clearance for IAV, EPEC, and SE infections.
- Simulations blocking TNF and IL-1 failed to reduce systemic damage, indicating limitations in targeting these pathways for CS.
Conclusions:
- Host PCDP redundancies are crucial for broad-spectrum pathogen defense but pose challenges for immunomodulatory therapies targeting CS.
- Integrative simulation models like PCDABM are valuable for identifying therapeutic targets to mitigate CS while preserving host defense.
More Related Videos
10:03Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids
Published on: August 2, 2024
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
The Extrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway
Caspases
Differentiation of Common Myeloid Progenitor Cells